Last update :
08/05/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Vasodilator   Papaverine hydrochloride  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
DBL papaverine hydrochloride New Zealand
Papaverin Recip Sweden
Papaverine chlorhydrate France, Malaysia
Stability of mixtures   Injection   Stability of mixtures : Papaverine hydrochloride     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass None 30 mg/ml
Injection   Papaverine hydrochloride   
Injection   Phentolamine mesylate 0,5 mg/ml
25°C
30 Day
Not specified 456
Level of evidence A
Glass None 30 mg/ml
Injection   Papaverine hydrochloride   
Injection   Phentolamine mesylate 0,5 mg/ml
5°C
30 Day
Protect from light 456
Level of evidence A
Glass NaCl 0,9% + antibacterial 4,5 mg/ml
Injection   Papaverine hydrochloride   
Injection   Alprostadil 12,5 µg/ml
Injection   Phentolamine mesylate 0,125 mg/ml
-20°C
180 Day
Protect from light 1899
Level of evidence A
Glass NaCl 0,9% + antibacterial 4,5 mg/ml
Injection   Papaverine hydrochloride   
Injection   Alprostadil 12,5 µg/ml
Injection   Phentolamine mesylate 0,125 mg/ml
4°C
30 Day
Protect from light 1899
Level of evidence A
Polypropylene Sodium chloride 0,9% 15 mg/ml
Injection   Papaverine hydrochloride   
Injection   Alprostadil 15 µg/ml
Injection   Urapidil 2 mg/ml
2-8°C
55 Day
Protect from light 3448
Level of evidence B
  Mentions Légales